RecruitingNCT06248229
Dyanavel XR or placebo for fatigue in adults with ADHD
About this title
Read the official source — NCT06248229This study evaluates the effectiveness of Dyanavel XR for people with ADHD.
Medication studyAges 18–65United States
Understand this study
What is this study about?
This study evaluates the effectiveness of Dyanavel XR for people with ADHD.
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- Rochester HillsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 1, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 50
- Sponsor
- Rochester Center for Behavioral Medicine
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06248229
- Official title
Show the full official title
A Single Center, Flexible-Dose, 10-Week, Randomized, Double-Blinded, Placebo-Controlled, Clinical Trial To Study The Efficacy Of Dyanavel XR In Treating Co-Occurring Fatigue In Adults With Attention Deficit/Hyperactivity Disorder (ADHD)
Recruitment & locations
RecruitingRochester Hills
A listed location does not confirm current availability.
Questions about this study
What is this study about?
This study evaluates the effectiveness of Dyanavel XR for people with ADHD.
Who is behind this study?
The study sponsor is Rochester Center for Behavioral Medicine, a pharmaceutical company.
Does this study involve medication?
Yes. The study involves medication, including Dyanavel XR and Placebo.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
